ACLX Arcellx Inc

USD 72.26 -4.79 ( -6.22%)
Icon

Arcellx Inc (ACLX) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 72.26

-4.79 (-6.22%)

USD 4.28B

0.88M

USD 100.41(+38.96%)

USD 26.50 (-63.33%)

Icon

ACLX

Arcellx Inc (USD)
COMMON STOCK | NSD
USD 72.26
-4.79 ( -6.22%)

Arcellx Inc (ACLX) Annual Income Statement (USD)

ACLX Quarterly Financials (USD)

Frequently Asked Questions About Arcellx Inc (ACLX) Stock

Arcellx Inc's (ACLX) last reported annual revenue was USD 110.32 Million.

Arcellx Inc's (ACLX) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Arcellx Inc's(ACLX) is not profitable as of its last reported annual financials.

The net profit margin for Arcellx Inc's(ACLX) from its laster reported year is -64.08%

The return on equity (ROE) for Arcellx Inc's(ACLX) from its last reported annual financials is : -10.79%

The return on assets (ROA) for Arcellx Inc's(ACLX) from its last reported annual financials is : -6.29%

The return on invested capital (ROIC) for Arcellx Inc's(ACLX) from its last reported annual financials is : -26.23%

The Debt to Equity ratio for Arcellx Inc's(ACLX) from its last reported annual financials is : 0.00%

The dividend yield for Arcellx Inc's(ACLX) from its laster reported year is 0.00%

Arcellx Inc's(ACLX) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...